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Glutamate-induced excitotoxicity is a major contributor to motor neuron
degeneration in the pathogenesis of amyotrophic lateral sclerosis (ALS). The
spinal cord × Neuroblastoma hybrid cell line (NSC-34) is often used as a bona
fide cellular model to investigate the physiopathological mechanisms of ALS.
However, the physiological response of NSC-34 to glutamate remains insufficiently
described. In this study, we evaluated the relevance of differentiated NSC-34
(NSC-34D) as an in vitro model for glutamate excitotoxicity studies. NSC-34D
showed morphological and physiological properties of motor neuron-like cells and
expressed glutamate receptor subunits GluA1–4, GluN1 and GluN2A/D. Despite
these diverse characteristics, no specific effect of glutamate was observed on
cultured NSC-34D survival and morphology, in contrast to what has been described in
primary culture of motor neurons (MN). Moreover, a small non sustained increase
in the concentration of intracellular calcium was observed in NSC-34D after
exposure to glutamate compared to primary MN. Our findings, together with
the inability to obtain cultures containing only differentiated cells, suggest that
the motor neuron-like NSC-34 cell line is not a suitable in vitro model to study
glutamate-induced excitotoxicity. We suggest that the use of primary cultures
of MN is more suitable than NSC-34 cell line to explore the pathogenesis of
glutamate-mediated excitotoxicity at the cellular level in ALS and other motor neuron
diseases.
Keywords: ALS, Ca2+ influx, differentiation, NSC34, glutamate receptors, NMDA
Abbreviations: α-MEM, Alpha-modified Eagle’s medium; ALS, amyotrophic lateral sclerosis; AMPA, α-amino-3-hydroxy-
5-methyl-4-isoxazole propionic acid; Ca2+, Calcium ion; DAPI, 4,6-diamino-2-phenylindole; DMEM, Dulbecco’s modified
Eagle’s medium; FCS, fetal calf serum; KA, kainite; MEM-NEAA, modified Eagle’s medium non-essential amino acids;
NSC, Neuroblastoma × Spinal Cord; NSC-34D, differentiated NSC-34; MN, motor neurons; NTFs, neurotrophic factors;
PBS, phosphate buffered saline; P/S, penicillin/streptomycin; RA, all-trans retinoic acid.
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INTRODUCTION
Amyotrophic lateral sclerosis (ALS) is one of the most common
neurodegenerative diseases in adults, caused by the selective
death of motor neurons (MN). Studies of the physiology of
ALS support the involvement of genetic factors and micro-
environmental factors with mechanisms such as glutamate
excitotoxicity and oxidative stress, but these mechanisms await
elucidation. Glutamate excitotoxicity is a major contributor to
dysfunction and death of MN in the pathogenesis of ALS (Heath
and Shaw, 2002; Van Den Bosch et al., 2006; Spalloni et al.,
2013; Blasco et al., 2014). Among the many drugs targeting
this pathogenic mechanism tested in clinical trials (Blasco et al.,
2014), one treatment (riluzole) is used in common practice to
slow the progression of the disease by blocking glutamatergic
neurotransmission in the central nervous system. However,
the mechanisms of toxicity caused by glutamate and their
links with other physiopathological pathways remain poorly
understood.
Overstimulation of glutamate receptors facilitates the entry
and consequently the excess of calcium (Ca2+) in cell
compartments, leading to a cascade of destructive events
by calcium-dependent enzymatic pathways and mitochondrial
dysfunction with the generation of free radicals (Van Den Bosch
et al., 2000; Blasco et al., 2014). Glutamate receptors are divided
into two families: the ligand-gated cation channels (ionotropic;
Lodge, 2009) and G protein-coupled receptors (metabotropic;
Niswender and Conn, 2010). Ionotropic receptors are further
divided into three categories according to their non-natural
preferred agonists, i.e., AMPA (α-amino-3-hydroxy-5-methyl-
4-isoxazole propionic acid), NMDA (N-methyl-D-aspartate)
and kainate (AK; Lodge, 2009). AMPA and NMDA receptors
are largely responsible for calcium flux across neuronal cell
membranes (Hollmann et al., 1991; Van Den Bosch et al.,
2000).
Primary cultures of MN (Krugman et al., 1999) and
cultures of different cell lines are used to study the molecular
mechanisms of neurotoxicity induced by glutamate in MN.
The most common cell line used in ALS research is the
spinal cord neuron × neuroblastoma hybrid cell line (NSC-34),
which was originally described as having several morphological
and physiological properties of MN (Eggett et al., 2000;
Rembach et al., 2004; Benkler et al., 2013; Maier et al.,
2013; Valbuena et al., 2015). We required validation of this
model to study the metabolic effects of glutamate excitotoxicity
in a neurological disease. NSC-34 is an hybrid cell line
produced by the fusion of MN from the spinal cords of
mouse embryos with mouse neuroblastoma cells N18TG2
(Cashman et al., 1992). These cells exhibit properties of MN
when subjected to protocols of differentiation and maturation.
Although NSC-34 cells share many features with MN such as
long processes and S-laminin with leucine-arginine-glutamate
(LRE) adhesion motif (a specific basal lamina glycoprotein
concentrated at the neuromuscular synapse; Hunter et al.,
1991), the formation of contacts with myotubes in culture
(Cashman et al., 1992) and increased survival in the presence
of neurotrophic factors (NTFs; Turner et al., 2004), their
functional properties when stimulated by glutamate have
rarely been studied (Durham et al., 1993; Eggett et al.,
2000).
The selective motor neuronal cell death in ALS is highly
dependent on intracellular Ca2+ and is insensitive to inhibitors
of voltage-operated Ca2+ and Na+ channels (MacDermott
et al., 1986; Van Den Bosch et al., 2000, 2006; Heath and
Shaw, 2002). Thus, the permeability of glutamate receptors
to Ca2+ seems crucial to validate the NSC-34 model as
appropriate for the exploration of glutamate excitotoxicity.
In order to evaluate whether NSC34 represents a relevant
model for studies on glutamate-induced neurotoxicity, we
differentiated the NSC-34 cells by serum depletion in the
presence or absence of all-trans retinoic acid (RA; Clagett-Dame
et al., 2006; Maden, 2007), and analyzed the expression and
functionality of glutamate receptors. We compared for the first
time the usefulness of NSC-34 cells (using various differentiation
protocols) and primary motor neuron cultures (used as the
reference) as models for glutamate induced-excitotoxicity in the
same study.
MATERIALS AND METHODS
Materials
Dulbecco’s modified Eagle’s medium (DMEM, Gibco),
DMEM-Ham’s F12 and Alpha-modified Eagle’s medium
(α-MEM), modified Eagle’s medium non-essential amino
acid (MEM-NEAA), penicillin/streptomycin (P/S), Trizol,
Superscript II reverse transcriptase kit and Fura-2 acetoxymethyl
ester were all obtained from Invitrogen (Life Technologies, Saint
Aubin, France), L-glutamic acid and all-trans RA from Sigma
Aldrich (Saint-Quentin Fallavier, France) and fetal calf serum
(FCS) from Eurobio (Courtaboeuf, France).
Culture of NSC-34
The NSC-34 was obtained from Cedarlane Laboratories (via
Tebu-Bio, Le Perray en Yvelines, France). Cells were cultured
as described previously (Madji Hounoum et al., 2015). Cultures
were used 5–15 passages. Each type of experiment was performed
on the same passage. No sub-culture passage was performed for
differentiated NSC-34.
For differentiation, NSC-34 cells were grown to confluence
and the proliferation medium (DMEM plus 10% FCS) was
exchanged for fresh differentiation medium every 3 days.
Cells were allowed to differentiate for up to 4 weeks. Three
differentiation media were investigated: (1) 1:1 DMEM/Ham’s
F12 plus 1% FCS, 1% P/S and 1% MEM-NEAA, the most
commonly used medium for NSC-34 differentiation (Kruman
et al., 1999; Eggett et al., 2000; Rembach et al., 2004; Benkler et al.,
2013); (2) α-MEM [themedium used for another neuron-like cell
line (P19; MacPherson et al., 1997)] plus 1% FCS, 1% P/S and 1%
MEM-NEAA; and (3) DMEM (the classic medium for NSC-34
culture) plus 1% FCS and 1% P/S.
Two conditions were investigated for all differentiation
media, i.e., with or without RA [1µM, as used previously (Johann
et al., 2011; Maier et al., 2013)]. NSC-34 cells, maintained on
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proliferation medium, served as the undifferentiated control
group. The average length of neurites in the differentiation
media was quantified using Sholl’s method for quantification
of dendritic branching in hippocampal neurons (Sholl, 1956).
Briefly, concentric circles at 25 µm intervals between adjacent
circles were drawn on Powerpoint, at the same magnification
of cell pictures. The center of the circle centered on the soma
of the cell, the lengths of the processes were measured from
the soma by multiplying the number of intersections (neurite-
circle) every 25 µm. Cells with neurites longer than 50 µm
were considered as differentiated. Neurite length was analyzed by
imaging a minimum of 10 cells per experiment, four experiments
for each condition.
Primary Motor Neuron Cultures
Studies were conducted using primary cultures of motor neuron
from the spinal cords of C57BL/6 mice at embryonic day 12.5
(Centre d’Elevage Roger Janvier, France). Cultures were grown
as described previously (Camu et al., 2014; Dangoumau et al.,
2015). MN were plated on poly-ornithine/laminin-treated wells
in the presence of NTFs (0.1 ng/mL GDNF, 1 ng/mL BDNF,
and 10 ng/mL CNTF in supplemented neurobasal medium
(Invitrogen, Carlsbad, CA, USA)). Supplemented neurobasal
medium contained 2% horse serum, L-glutamate (25 mM),
β-mercaptoethanol (25 mM), L-glutamine (0.5 mM), and 2%
B-27 supplement (Invitrogen, Life Technologies, Saint Aubin,
France). The use of appropriate culture medium combined with
multiple purification steps using density gradient (BSA cushion
and Optiprep density centrifugation) and magnetic cell sorting
with an indirect microbeads technique promoted the enrichment
of MN as well as the elimination of astrocytes and microglia cells
from the culture (Arce et al., 1999).
Immunocytochemistry
To assess morphological characterization of primary motor
neuron culture derived from embryonic spinal cord, expression
of βIII-tubulin and p75 neurotrophic receptor were analyzed
(Rembach et al., 2004). Cells were fixed in 4% paraformaldehyde
and then incubated in a blocking and permeabilizing solution
(10% donkey serum and 2% Triton X-100) for 1 h. The cells were
stained with rabbit anti-βIII-tubulin (1:200, Covance, Princeton,
NJ, USA) and mouse anti-nerve growth factor receptor (p75NTR
1:60, Chemicon MAB357) for 1 h. After being washed with
phosphate buffered saline (PBS), the cells were incubated with
secondary antibodies for 1 h. The secondary antibodies used
were donkey anti-rabbit Alexa-488 (1:300, Life Technologies,
Saint Aubin, France) and donkey anti-mouse Alexa-594 (1:300,
Life Technologies, Saint Aubin, France). Nuclear DNA was
observed by 4,6-diamino-2-phenylindole (DAPI) contained in
ProLongr (Life Technologies, Saint Aubin, France). Cells were
photographed using a confocal microscope (Olympus FV500).
Cell Viability Assay
To assess the effect of glutamate-induced excitotoxicity in
NSC-34D, cells were exposed to glutamate at different
concentrations (100 µM, 500 µM, 1 mM and 10 mM) for
48 h (Eggett et al., 2000; Rembach et al., 2004; Maier et al., 2013)
before determination of cell viability by trypan blue assay. A
control condition with no excitotoxic agent (PBS) was included
for comparison. Four replicates per condition were obtained.
The cells were harvested with trypsin and re-suspended in
culture medium before addition of trypan blue (0.4% w/v;
Molecular Probes-Invitrogen, Carlsbad, CA, USA). Living and
dead cells were counted accurately with a Countess Automated
Cell Counter (Invitrogen, Carlsbad, CA, USA). Motor neuron
survival was assessed by direct counting after exposing cells to
100 µM glutamate for 48 h.
RNA Extraction, Reverse Transcription
PCR (RT-PCR) and Real-Time Polymerase
Chain Reaction (RT-qPCR)
Following a wash in PBS, RNA samples were extracted from
NSC-34 cells and primary MN using Trizol and treated with
DNase I (Proteigener). Reverse transcription was performed
on 2.5 µg of treated RNA using the superscript II reverse
transcriptase kit according to the manufacturer’s instructions.
cDNA samples were analyzed using primers for subunits
of AMPA receptors (GluA1–4), NMDA receptors (GluN1,
GluN2A-D, GluN3A), and standard markers for MN such
as choline acetyltransferase (ChAT), p75 (Cashman et al.,
1992; Matusica et al., 2008; Maier et al., 2013; see Table
A1 in Supplementary Material). Actin was used as internal
standard. cDNA samples were amplified using GoTaqr Flexi
DNA polymerase (Promega) in 25 µL reaction mixture
containing 125 ng cDNA following the manufacturer’s
protocol. Amplification consisted of 34 cycles at 95◦C for
1 min, 59◦C for 1 min and 72◦C for 1.5 min. Aliquots
of 10 µL of these products underwent electrophoresis
on 1.5% agarose gel before capture with a ChemiDoc
XRS camera and quantification by Quantity One Software
(BioRad). Mouse brain extract was used as positive control for
amplifications.
The gene expression of glutamate receptor subunits, ChAT
and p75NTR, was measured by semi quantitative real-time
PCR (RT-qPCR) using the Brilliant III Ultra-Fast SYBRr
QPCR MM kit (AgilentTM) and the same primers as for
conventional RT-PCR (see Table A1 in SupplementaryMaterial).
The reaction was performed in a LightCycler 480 (Roche
Diagnostic, Meylan, France) at Tm 60–62◦C. The efficiency
of amplification was calculated on cDNA at concentrations
ranging from 3.75 to 60 ng/mL. To ensure the absence of
genomic DNA contamination, a control sample of non-reverse-
transcribed RNA was run for each set of RNA extractions.
The expression’s stability of reference genes was determined
following MIQE guidelines (Bustin et al., 2009). We showed
that β-actin and GAPDH genes were stably expressed (data
not shown). Relative quantification was obtained by calculating
the ratio between the values obtained for each gene of
interest and the reference genes (β-actin, GAPDH). Melting
curves were routinely performed to determine the specificity
of the qPCR reaction. The 2−∆∆Ct method was used for
analysis.
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Measurement of Calcium Influx
Cells were seeded on coverslips at a density of 3 × 104 cells/mL
and allowed to grow for 2 days. They were loaded with a
fluorescent probe (1 µM Fura-2 AM) in culture medium for
45 min at 37◦C. Cells were then washed with medium and
allowed to de-esterify for at least 15 min at room temperature.
The dish was then placed on the stage of a Nikon Eclipse
TE2000-S inverted fluorescence microscope (Nikon, France)
equipped with a 75 W Xenon Arc Lamp (Ushio, Japan), an
Optoscan Monochromator (Cairn Optoscan, Kent, UK), and an
ORCA-03G (CCD) camera (Hamamatsu, Japan). The coverslips
were placed in a perfusion chamber containing physiological
solution with 2 mM calcium (see Table A2 in Supplementary
Material).
Excitation light was chopped by the monochromator at the
two excitation wavelength maxima of fura-2 (340/380 nm).
The excitation protocol used was a 500 ms excitation at each
wavelength every 4 s. Fluorescence emission at 510 was detected
by the CCD digital camera. The software (Imaging workbench 6)
excited cells and allowed acquisition of images. The acute effects
of glutamate at 100 µM and 1 mM (for primary MN and
NSC-34D, respectively) on calcium entry were measured in
physiological solution for 200 s. For primary motor neuron
cells, we first determined the optimal time window allowing
the experiment by measuring calcium entry every 2 days on
independent replicates (cells that had not been exposed to fura-2
experiment before).
Statistical Analysis
Data was expressed as the mean ± SEM values. Statistical
significance was determined using the Mann-Withney test or
one-way Anova. For multiple comparisons, Tukey’s tests were
used as post hoc tests or Kruskal-wallis test for appropriate
analyses. For all analyses, p values < 0.05 were considered
significant. The type of statistical test is specified in each figure
legend.
RESULTS
Efficient Differentiation of NSC-34 Cells
into Motor Neuron-Like Cells
When NSC-34 cells were cultured in the differentiation
media (NSC-34D), we distinguished two morphologically
distinct populations: cells with short neurites, and cells
with phenotypic characterization of MN with long processes
(Figure 1A). However, this differentiation was preceded by
a massive loss of cells (>50%) as described by Eggett et al.
(2000), with surviving cells sprouting extensive neuron-like
projections.
We next investigated whether the potent morphogen RA
could enhance differentiation of NSC-34 into motor neuron-like
cells. We found that addition of RA (1 µM) in differentiation
medium resulted in a significant decrease (60–70%) in
proliferation at 4 days. Surviving cells showed a very low rate of
proliferation compared to conditions without RA, as previously
shown (Johann et al., 2011). However, we observed that a
FIGURE 1 | (A) NSC-34 cells grown for 4 weeks in differentiation media with
or without addition of all-trans retinoic acid (RA): DMEM/Ham’s F12, α-MEM
and DMEM. (B) Morphological differentiation of NSC-34 cells determined by
measurement of neurite length. Statistically significant difference from
differentiated cells without addition of RA was defined using Mann-Whitney
test, according to the different media: DMEM/Ham’s F12, α-MEM and DMEM.
Values are means ± SEM (10–11 cells per experiment and four experiments
for each condition), ∗p < 0.001, ∗∗p < 0.0001, ns = not significant,
Mann-Whitney test + RA vs. none.
significant proportion of surviving cells had a motor neuron-like
phenotype (∼80%) in the presence of RA as determined by
morphological criteria (Figure 1A).
We then assessed whether differentiation conditions could
potentiate the effects of RA on process outgrowth of NSC-34
cells. We determined the average neurite length of NSC-34 cells
when they are maintained for 4 weeks in three differentiation
media (α-MEM, DMEM/Ham’s F12 and DMEM) in the presence
or absence of RA. We found that the average neurite length has
increased by 55% when they are cultured in α-MEM media with
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RA compared to α-MEMmedia without RA (240.00± 15.89 and
154.16 ± 7.01, respectively, p < 0.0001). While it has decreased
by 20% when cells were cultured in DMEM/Ham’s F12 media
with RA compared to media without RA (181.82 ± 11.29 and
229.69 ± 12.09, respectively, p < 0.001; Figure 1B). We did not
find any significant change when NSC-34 cells were cultured in
DMEM with or without RA (200.45± 11.95 and 206.25± 13.13,
respectively, p = 0.46). Therefore, the effects of RA on NSC-34D
cell morphology were highly dependent on the differentiation
medium (Figure 1B).
Differentiated NSC-34 Cells Expressed
Glutamate Receptor Subunits
We first set up conditions for optimal and specific amplification
of glutamate receptor subunits GluA1–4, GluN1, GluN2A-D and
GluN3A using total RNA obtained frommouse brain extract (see
Figure A1 in Supplementary Material). We next studied the
expression profiles of all glutamate receptors promoted by
NSC-34 differentiation (up for 4 weeks) and in primary MN. We
found that the differentiation of NSC-34 in the conditions that we
had previously described induced a significant increase inmRNA
expression of glutamate receptor subunits GluN1, GluN2A and
GluN2D compared to undifferentiated cells (Figures 2B–I).
The example of GluN2A protein confirms this statement:
the result obtained by western blot analysis showed that
the GluN2A protein level in NSC-34D was higher than in
undifferentiated NSC-34 (see Figure A2 in Supplementary
Material). Levels of GluA4 subunits mRNA have increased in
DMEM without RA compared to the other conditions without
RA (Figures 2C,E,G). At more discrete levels, we also observed
increases of GluA2 and GluA3 mRNA in DMEM/Ham’s F12
and α-MEM but not in DMEM. We noted the expression of
all glutamate subunits in primary MN, as observed in mouse
brain extracts (Figure 2A and Figure A1, see Supplementary
Material).
We found that the presence of RA promoted the expression of
GluA4 mRNA in every differentiation medium (Figures 2C–H).
However, mRNA expression of the other subunits of glutamate
receptors was not modified by the presence of RA in the
culture medium. The differentiation condition that promoted
most of the glutamate receptors and that generated less
heterogeneity bias was thus DMEM-Ham’s F12 without RA.
Indeed, this differentiation condition led to expression of all
AMPR subunits (GluA1–4) and half of the NMDAR subunits
(GluN1, GluN2A, and GluN2D), as summarized in Table A3
(see Supplementary Material). However, expression of AMPR
subunits was lower compared to primaryMN (Figures 2A,C,I,J).
DMEM-Ham’s F12 without RA medium is used for further
explorations. Our results also showed that NSC-34D cells
expressed many motor neuron properties such as ChAT and
p75NTR (Figures 2C–H). RA-differentiated NSC-34 did not
express more receptor subunits than NSC-34D without RA
(Figures 2C–H and Table A3 in Supplementary Material). We
next semi quantified expression of glutamate receptor subunits
in NSC-34D differentiated in DMEM-Ham’s F12 without RA
condition compared to MN.
Expression of Receptor Subunits
RT-qPCR analysis revealed high levels of expression of
GluN1, GluN2A and GluN2D mRNA (CP values were
8.35 × 10−3 ± 4.96 × 10−5, 3.02 × 10−3 ± 6.30 × 10−8
and 4.95 × 10−4 ± 1.83 × 10−6, respectively) in NSC-34
differentiated in DMEM/Ham’s F12 without RA, while
expression of GluA1, GluA2, GluA4, GluN2C and GluN3A
mRNA (9.85× 10−7 ± 4.02× 10−9, 4.45× 10−7 ± 5.78× 10−9,
7.45 × 10−6 ± 5.77 × 10−9, 3.22 × 10−6 ± 1.80 × 10−7 and
9.74 × 10 −6 ± 2.01 × 10−8, respectively) was low in NSC-34D
(Figures 2I,J), i.e., as for the results of conventional RT-PCR
(Figure 2C). GluA3, and GluN2B mRNA levels were almost
zero in NSC-34D (Figures 2I,J). It is of note that only 20% of
the cells did not express motor neuron-like morphology. The
results showed that primaryMN expressed all glutamate receptor
subunits at different levels, unlike to NSC-34D. Consistently
with RT-PCR data, the transcript profile of NSC-34D glutamate
receptor subunits is different from that of MN.
Differentiated NSC-34 Cells did not Show
Susceptibility to Glutamate-Induced Death
We investigated whether glutamate could trigger death of
differentiated NSC-34 cells. NSC-34D cells were exposed
to increasing concentrations of glutamate ranging from 0.1
to 10 mM. We found 102.04 ± 3.63%, 104.08 ± 8.03%,
94.90 ± 1.44%, 86.73 ± 4.17% and 64.28 ± 2.89% of relative
cell viability when cells exposed to 0.1 mM, 0.5 mM, 1 mM,
5 mM and 10 mM glutamate, respectively (Figure 3A). We also
evaluated excitotoxicity death of MN at 8 DIV (Days In Vitro)
exposed to 0.1 mM glutamate and we found 53.99 ± 3.04%
of relative cell viability (Figure 3B). We observed that 48 h
exposure to 0–5 mM glutamate did not elicit any toxic response
to NSC-34D, and a non-specific effect of about 30% on cells
survival was found when glutamate was added at 100-fold higher
concentrations (10mM; Figure 3A) than that necessary to induce
50% death of primary MN (0.1 mM; Figure 3B). The results
show that NSC-34D cells do not show the same susceptibility to
glutamate-induced excitotoxicity compared to MN.
Glutamate did not Elicit Sustained Calcium
Entry into NSC-34D
Glutamate-induced excitotoxicity resulted in elevated
intracellular calcium levels via ionotropic glutamate receptors
and activation of cell death signaling pathways. To address
the effects of glutamate on Ca2+ transients in NSC-34D, we
used ratiometric Ca2+ measurement with the imaging dye
Fura-2AM. To establish sensitive and accurate measurement of
intracellular Ca2+, we used motor neuron-enriched cultures.
When MN were purified from E12.5 embryos as described
above, a culture containing about 70% MN was identified using
the p75NTR generic marker (Figure A3-A see Supplementary
Material). The phase-bright soma with long motor neuron
processes made them clearly distinguishable from other cells
(Figure A3 see Supplementary Material). Their maturity was
tested every 2 days by measuring [Ca2+] influx to determine
the optimal time window allowing the experiment. We found
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FIGURE 2 | Characterization of the expression of glutamatergic receptors in motor neurons (MNs) and NSC-34D cells. Conventional RT-PCR on RNA
isolated from NSC-34 cells maintained in the proliferation medium (undifferentiated) (A), from MNs (B), and from NSC-34 cells grown in three differentiation media
with or without all trans-retinoic-acid (AR) for 4 weeks: (C,D) DMEM/Ham’s F12, (E,F) MEM and (G,H) DMEM. (I) Semi-quantitative RT-qPCR analysis of gene
expression of glutamate receptor subunits in MN and NSC-34 differentiated in DMEM/Ham’s F12 media without RA (mean ± SEM, n = 3). (J) Semi quantification of
the differences in RT-qPCR between MN and NSC-34D in DMEM/Ham’s F12 media without RA (mean ± SEM, n = 3).
that younger MN did not efficiently load Fura-2AM before
5 DIV (data not shown). We observed that MN showed robust
fluorescence signal from 5 DIV and glutamate induced a robust
Ca2+ influx in MN at 12 DIV (Figure A3-B, see Supplementary
Material). The maximum fura-2 fluorescence intensity relative
to baseline was significantly higher (p< 0.005) in MN at 12 DIV
(0.0293 ± 0.0026) and 13 DIV (0.0320 ± 0.0004) compared
to those at 5 DIV (0.0019 ± 0.0002). There was no significant
difference between MN at 12 DIV and 13 DIV. Subsequent
experiments were therefore performed using 13-day-old cultures
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FIGURE 3 | (A) Effects of glutamate on NSC-34D cell cultured in DMEM/Ham’s F12 without RA. Cells were exposed to increasing concentrations of glutamate
(ranging from 0.1 to 10 mM) for 48 h before counting. (B) Effects of glutamate on survival of primary MN, cells were exposed at 8 DIV to 0.1 mM glutamate for 48 h
before counting. Data were analyzed by Mann-Whitney test or Kruskal-Wallis (multiple comparisons) to detect statistical significance. Statistically significant difference
from untreated cells ∗p < 0.05, ∗∗p < 0.01. Data are mean ± SEM (n = 3).
(Figure A3-B, see Supplementary Material). At 13 DIV, the MN
are fully mature with electrical activity (Jackson et al., 1982;
Nicola et al., 1992; Chang and Martin, 2011).
We then investigated the functionality of glutamate receptors
expressed in NSC-34D growing in DMEM/Ham’s F12 medium
without RA for 4 weeks through Ca2+ permeability. The baseline
recordings (first 0.5 min in all trace graphs) demonstrate
stable cytosolic calcium levels in both MN and NSC-34D cells
before treatment with glutamate. The addition of glutamate
immediately increased the fluorescence intensity of the calcium-
sensitive dye Fura-2, indicating increased cytosolic Ca2+ flux in
MN (Figure 4A). Whereas MN presented a sustained calcium
entry following acute stimulation by glutamate (0.1 mM),
glutamate stimulation in NSC34D resulted in a small transient
calcium entry (Figure 4B). However, in the presence of
glutamate, Ca2+ entry into MN was significantly higher
than in NSC-34D cells, and the signal was as consistent
as that obtained by fura-2 fluorescence intensity relative to
baseline (0.032 ± 0.0004 vs. 0.009 ± 0.0012; ∗p < 0.001;
Figure 4C). Taken together, these results showed that an
increased extracellular glutamate concentration (1 mM) did not
elicit the same calcium response in NSC-34D cells (Figure 4C) as
in MN.
DISCUSSION
Although glutamate-mediated excitotoxicity is known to be
involved in ALS pathogenesis (Beal, 1992; Mattson et al., 1992),
the precise mechanisms leading to electrical, metabolic or
signaling dysfunction in the motor neuron diseases remain to
be determined. Excitotoxicity mechanisms have been described
following in vitro studies using either primary motor neuron
cultures (Kruman et al., 1999; Van Den Bosch et al., 2000; Dolga
et al., 2011; Joshi et al., 2011) or cell lines (Rembach et al.,
2004; Benkler et al., 2013). The advantage of primary cultures is
the development of similar in situ counterpart morphology and
physiology over time. The neurotoxicity of a variety of toxins
in situ has also been reported (Durham et al., 1993). However,
due to the low yields of motor neuron cultures, the NSC-34 cell
line has been widely used and tacitly considered to be the most
stable motor neuron cell line to model ALS pathophysiology
(Veyrat-Durebex et al., 2014). Indeed, many studies have shown
that the differentiation process can induce NSC-34 cells to
express certain motor neuron properties and have shown some
toxic effects following exposure to glutamate (Eggett et al., 2000;
Benkler et al., 2013; Maier et al., 2013). The differentiation and
the maturation of NSC-34 cells are generally characterized by
extension of neurites and expression of certain motor neuron-
specific proteins. In this study, we investigated the reliability
of these cells as an in vitro model to study glutamate-mediated
neurotoxicity, using an approach from receptor expression to the
Ca2+ influx.
Differentiation of NSC-34 Cells into Motor
Neuron-Like Cells
Differentiation of cell lines frequently requires modification
of the culture medium through serum depletion and/or and
use of chemical reagents or metabolites such as RA to obtain
more neuron-like properties, including neurite outgrowth and
morphological changes (MacPherson et al., 1997; Eggett et al.,
2000; Maier et al., 2013). As reported in the literature, we
found that the differentiation process induced NSC-34 cells to
express phenotypic MN with long processes (Figure 1A and
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FIGURE 4 | Acute effects of 100 mM and 1 mM glutamate (for primary
MN and NSC-34D, respectively) for 200 s on calcium entry.
Representative fluorescence measurement of Ca2+ entry in MN (A) and
NSC-34D (B) after acute application of glutamate. Glutamate was added at
the time indicated by the arrow. (A) Mean traces of cytosolic Ca2+ flux of MN
and (B) NSC-34D in response to glutamate. (C) Histograms showing
maximum fluorescence intensity following glutamate application in MN and
NSC-34D. Mean data ± SEM from three coverslips per cell type with at least
five cells per coverslip analyzed. ∗p < 0.001 (Mann-Whitney test MN vs.
NSC-34D).
Figure A3-A, see Supplementary Material). We found that the
RA effects on NSC-34D cell morphology were highly dependent
on the differentiation medium (Figure 1B). Importantly, we
did not observe any effect on undifferentiated NSC-34 cells as
previously demonstrated (Cashman et al., 1992; Maier et al.,
2013). We also evaluated the RA effects on the expression
of genes encoding certain specific motor neuron proteins
and glutamate receptor subunits, and we found that RA-
differentiated NSC-34 did not express more receptor subunits
than NSC-34D without RA (Figures 2C–H and Table A3, see
Supplementary Material), thus suggesting that using RA is not
required in NSC-34 differentiation processes in the context
of excitotoxicity studies. This conclusion is supported by the
results obtained by Cheung et al. (2009) who showed that RA
differentiation conferred higher tolerance of SH-SY5Y cells to
neurotoxin (6-hydroxydopamine) compared to undifferentiated
SH-SY5Y cells, and they suggested that RA-differentiated SH-
SY5Y was not appropriate for neurotoxicity or neuroprotection
studies.
The Receptor Subunits Expressed by
NSC-34D
NMDARs and AMPARs have critical roles in excitatory synaptic
transmission, plasticity and excitotoxicity in the CNS. We
found that NSC-34D expressed more receptor subunits in
DMEM/Ham’s F12 medium without RA than in other media
(Figures 2C–H and Table A3, see Supplementary Material).
NSC-34D expressed all AMPAR (GluA1–4) and some NMDAR
(GluN1, GluN2A/B) subunits, as reported in the literature
(Eggett et al., 2000; Rembach et al., 2004). We therefore chose
DMEM/Ham’s F12mediumwithout RA for further experiments.
Then we compared expression of glutamate receptor subunits
on primary MN and NSC-34D using RT-qPCR (Figures 2I,J).
The results showed that primary MN expressed all glutamate
receptor subunits at different levels, in contrast to NSC-34D
which expressed some of them at times and in very small
quantities. This clearly showed that the transcript profile of
NSC-34D glutamate receptor subunits was different from that
of MN and very consistent with RT-PCR and RT-qPCR data,
indicating that NSC-34D could not be used as a model of primary
MN for glutamate-mediated excitotoxicity.
No Glutamate-Induced Toxicity in NSC-34D
Glutamate concentrations in the extracellular fluid are
normally around 0.8–2.9 µM (Lerma et al., 1986). A rise
in the extracellular glutamate concentration to 2–5 µM is
considered sufficient to cause degeneration of neurons through
excessive stimulation of glutamate receptors (Rosenberg et al.,
1992). When investigating glutamate-induced excitotoxicity at
the cellular level, the glutamate concentrations used to obtain
effects varied according to the in vitro models investigated and
exposure times. For primary cultures, the range of glutamate
concentrations used to act on ionotropic glutamate receptors
(Van Den Bosch et al., 2000) was between 10 µM–1 mM,
and cultures were exposed for less than 24 h (Mattson
et al., 1995; Kruman et al., 1999; Sen et al., 2008). As in our
study (Figure 3B), it had previously been demonstrated
that exposure of primary embryonic MN to glutamate
(0.1 mM) for 24 or 48 h led to approximately 50% cell death
(Metzger et al., 1998; Urushitani et al., 1998), whereas for
Frontiers in Cellular Neuroscience | www.frontiersin.org 8 May 2016 | Volume 10 | Article 118
Madji Hounoum et al. Glutamate Excitotoxicity: NSC-34, Unsuitable Model
cell lines, this glutamate concentration range was increased
to 10 mM with longer exposure times (24–72 h; Eggett et al.,
2000; Rembach et al., 2004; Benkler et al., 2013; Maier et al.,
2013). In our study, we investigated the toxicity of glutamate
on NSC-34D and motor neuron survival. The results showed
approximately 50% cell death at 100 µM glutamate for primary
MN (Figure 3B), as described in the literature (Metzger et al.,
1998; Urushitani et al., 1998). For NSC-34D cells, we found
a significant loss of viable cells at a concentration of only
10 mM glutamate (Figure 3A). This result is consistent with
previous excitotoxicity studies on NSC-34D where treatment
with glutamate (up to 1 mM) failed to induce vacuolation of
NSC-34D, in contrast to the effects on primary MN (Durham
et al., 1993).
Among the different neuroprotectivemechanisms in neurons,
neurotrophin factors may play a key role. Literature reported
that NTFs and glutamate interact to regulate developmental
and adult neuroplasticity (Mattson et al., 1995; Mattson,
2008). Consequently, neurotrophin factors attenuated elevation
of intracellular calcium concentrations induced by glutamate
(Mattson et al., 1995), thus promoting the survival of neurons
(McKay et al., 1996; Giménez y Ribotta et al., 1997; Vincent et al.,
2004; Mattson, 2008) via the MAPK and PI-3K/Akt pathways
(Vincent et al., 2004).
To validate the glutamate-sensitive motor neuron NSC-34
cell line, many studies have used modified growth conditions
through serum depletion to induce differentiated NSC-34 cells
and to investigate the cytotoxicity of glutamate or other
excitotoxins (AMPA, 5-fluorowillardiine, H2O2, TNF-α, etc.) in
the presence or absence of receptor antagonists by using viability
tests (Rembach et al., 2004; Hemendinger et al., 2012; Benkler
et al., 2013; Maier et al., 2013). In some cases, they evaluated the
expression of certain genes which encode cholinergic phenotype-
related proteins (ChAT, acetylcholine esterase and vesicular
acetylcholine transferase; Maier et al., 2013). It should be
emphasized that most studies that used cell line models to
investigate glutamate neurotoxicity focused predominantly on its
toxic action and not on the functional properties of glutamatergic
receptors such as Ca2+ permeability (Rembach et al., 2004;
Hemendinger et al., 2012; Benkler et al., 2013; Maier et al., 2013).
No Sustained Calcium Entry in NSC-34D
The stoichiometry of the receptor complexes in mammalian
cells seems to be largely controlled by the level of the
individual subunits expression that determine their functional
properties including Ca2+ permeability via glutamate receptors
(Hollmann et al., 1991; Monyer et al., 1992; Das et al., 1998;
Dingledine et al., 1999; Sobolevsky et al., 2009). According
to the literature evidence, the expression of GluA1–4, GluN1
and GluN2A or GluN2B subunits induces functional receptors.
Surprisingly, in our study, despite the expression of GluA,
GluN1 and GluN2A/D subunits in NSC-34D (Figure 2I),
we did not observe a significant sustained calcium entry as
demonstrated in MN (Figure 4C). In this study, we globally
evaluated the intracellular calcium concentrations (including
the interplay between extracellular and intracellular origin)
provoked by glutamate, through glutamate receptors by using
the Fura-2-AM. However, we cannot exclude the possibility
that part of the increase of cytosolic calcium could come from
internal stores. Using SH-SY5Y cells line and measurement of
calcium release from different compartments, Jaiswal et al. (2009)
provided evidences of the existence of two separate intracellular
Ca2+ stores (endoplasmic reticulum (ER) and mitochondrial
intracellular pools) which may participate in the generation of
intracellular Ca2+ signals. Calcium permeability via glutamate
receptors has also been shown to initiate a self-perpetuating
process of intracellular Ca2+ dysregulation with consecutive ER
Ca2+ release and mitochondrial Ca2+ overload (Jahn et al., 2006;
Grosskreutz et al., 2007, 2010). The ER and mitochondria form
a highly dynamic interconnected network that is involved in the
generation of Ca2+ signals (Tadic et al., 2014). A recent article
reported a Ca2+ influx in NSC-34D cells compared to a ‘‘negative
control’’ undifferentiated NSC-34 (Liu et al., 2015), but authors
did not compare calcium influx of these NSC-34D to that of MN
(as ‘‘positive control’’) which are the parent motor neuron for
NSC-34, as performed here in our study. We postulate that this
shift of Ca2+ entry in NSC-34D could be due to the fact that some
glutamate receptor subunits were not expressed or very weakly
expressed, in contrast to MN which showed a sustained calcium
entry following glutamate application.
Limitations in the Use of the NSC-34 Cell
Line
As mentioned above, Eggett et al. (2000) evaluated the use
of NSC-34 cells as a glutamate-sensitive motor neuron model.
Using immunocytochemistry, they demonstrated the presence
of glutamate receptor proteins GluN1, GluN2A/B, GluA1–4,
GluK2/3 and GluK5. Exposure to glutamate (1 mM) for 24 h
induced significant cell death (∼30%), and changes in calcium
cytosolic levels were observed. As in many other studies (Eggett
et al., 2000; Rembach et al., 2004; Benkler et al., 2013; Maier
et al., 2013; Liu et al., 2015) authors suggested that, because of
their motor neuron origin, the NSC-34 cell line could be used
to investigate excitotoxicity mechanisms. However, as reported
by Durham et al. (1993), in our study we found limitations in
the use of the NSC-34 cell line for neurotoxicity testing. Durham
et al. (1993) have evaluated the value of these cells by following
exposure of cultures to chemicals known to be neurotoxic for
MN. Authors showed that NSC-34 responded to agents that
affect voltage-gated ion channels, cytoskeleton organization and
axonal transport. However, no electrophysiological evidence was
shown, and exposure to glutamate (1 mM) had no effect on cell
morphology or potential production. They concluded that the
NSC-34 cell line was not a good model to investigate agents that
affect synaptic transmission (Durham et al., 1993). Hemendinger
et al. (2012) have demonstrated that riluzole in the neurorescue
paradigmwas unable to reduce cell death induced by neurotoxins
that increased intracellular calcium levels independently of ER
stress in NSC-34D cells, but they did not provide information on
the molecular basis. This finding may potentially be explained
by the fact that NSC-34 is not a suitable in vitro model to
investigate excitotoxicity. All these results together suggest that
NSC-34 cells may not be appropriate as an in vitromodel to study
glutamatergic toxicity in motor neuron degeneration. Motor
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neuronal properties evaluated on differentiated NSC-34 cells and
literature findings were summarized in the Appendix (Table A4,
see Supplementary Material).
Importantly, the phenotypes of NSC-34 may vary, according
to the repeated culture passage or to the origin of the cell line
[provided by Dr Neil Cashman (Durham et al., 1993; Maier
et al., 2013; Liu et al., 2015) or purchased (Hemendinger et al.,
2012)]. So, results may not be reproducible over time, from one
laboratory to another, and even within the same laboratory. We
cannot exclude the possibility that this contradictory findings
may be explained by the differences between basal features
of NSC-34 cells, rarely detailed in the studies (Eggett et al.,
2000; Rembach et al., 2004; Benkler et al., 2013). There
may be various differentiation processes with various media
and chemicals known to induce various NSC-34-expressed
motor neuron properties, and the culture conditions were not
systematically explored to seek optimal toxicity to glutamate.
However, in agreement with the literature, in our study we
did not find any condition which promoted expression of all
glutamatergic properties. The aim of this work was not to
focus on optimization of differentiation processes which should
involve several parameters (medium composition, differentiation
time, time of changingmedium, cell density, cell passage, etc.) but
rather to evaluate the versatility of the NSC-34 cell line to model
motor neuron susceptibility to glutamate-induced excitotoxicity.
Reliable validation is a crucial step before using a cell line as
an in vitro model in glutamate-induced excitotoxicity studies.
Such validation requires the evaluation of the biochemical
and electrophysiological processes of MN that are targets of
glutamate such as glutamate receptors and Ca2+ influx with a
‘‘positive control’’.
We could not exclude the possibility that the maturity was
insufficient to induce calcium influx in NSC-34D cells under the
present experimental conditions. Even if organotypic spinal cord
cultures remain the models that closely reflect in situ reality, we
suggest that the use of primary motor neuron culture is more
suitable than NCS-34 cell line to explore the pathogenesis of
glutamate-mediated excitotoxicity at the cellular level, in ALS
and other motor neuron diseases. However, different authors
have shown that NSC-34 cells remain a suitable model of
vulnerability to neurotoxins (Maier et al., 2013) and to investigate
the effects of cerebrolysin (Keilhoff et al., 2014). NSC-34 cells line
is a viable in vitro cell model for screening therapeutic candidates
against nerve agents (Kanjilal et al., 2014), investigating the
expression of transcription factors (Prell et al., 2012) and could
thus be a relevant model for some specific experiments.
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